Lataa...
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases
Rhenium-188-HEDP ((188)Re-HEDP) is a new and attractive radiopharmaceutical for the treatment of metastatic bone pain. As a product of (188)W/(188)Re generator, it is convenient for clinical therapeutic use with a short physical half-life of 16.9 h and a maximal β-energy of 2.1 MeV. We investigated...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2003
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2376909/ https://ncbi.nlm.nih.gov/pubmed/12915868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601158 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|